Search for other papers by Małgorzata Kałużna in
Google Scholar
PubMed
Search for other papers by Pola Kompf in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Jerzy Moczko in
Google Scholar
PubMed
Search for other papers by Aleksandra Królczyk in
Google Scholar
PubMed
Search for other papers by Adam Janicki in
Google Scholar
PubMed
Search for other papers by Karol Szapel in
Google Scholar
PubMed
Search for other papers by Marian Grzymisławski in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Search for other papers by Katarzyna Ziemnicka in
Google Scholar
PubMed
GI system disorder and one of the leading causes of absence from work ( 9 ). It is characterized by abdominal pain and changes in bowel habits, which allows classification of the condition into diarrhea- or constipation-predominant types, a mix of
Search for other papers by Emmi Naskali in
Google Scholar
PubMed
Search for other papers by Katja Dettmer in
Google Scholar
PubMed
Search for other papers by Peter J Oefner in
Google Scholar
PubMed
Search for other papers by Pedro A B Pereira in
Google Scholar
PubMed
Search for other papers by Kai Krohn in
Google Scholar
PubMed
Search for other papers by Petri Auvinen in
Google Scholar
PubMed
Search for other papers by Annamari Ranki in
Google Scholar
PubMed
Search for other papers by Nicolas Kluger in
Google Scholar
PubMed
questions regarding gastrointestinal function, that is, current chronic constipation or diarrhea (without any known cause) or both. The questionnaire was sent to all 37 patients. Twenty-six patients completed and returned the questionnaires (response rate
Search for other papers by Merete Gedde-Dahl in
Google Scholar
PubMed
Search for other papers by Espen Thiis-Evensen in
Google Scholar
PubMed
Search for other papers by Andreas Myklebust Tjølsen in
Google Scholar
PubMed
Search for other papers by Kjerstin Skrede Mordal in
Google Scholar
PubMed
Search for other papers by Morten Vatn in
Google Scholar
PubMed
Search for other papers by Deidi S Bergestuen in
Google Scholar
PubMed
with endocrine functions (1) . Small intestinal NETs often produce vasoactive substances that may result in the carcinoid syndrome, symptoms of which include flushing, diarrhea, carcinoid heart disease, and bronchospasm. The syndrome is almost
Search for other papers by Efstratios Kardalas in
Google Scholar
PubMed
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Panagiotis Anagnostis in
Google Scholar
PubMed
Search for other papers by Giovanna Muscogiuri in
Google Scholar
PubMed
Search for other papers by Gerasimos Siasos in
Google Scholar
PubMed
Search for other papers by Andromachi Vryonidou in
Google Scholar
PubMed
primary hyperaldosteronism, kidney disorders and genetic syndromes affecting the renal function ( 19 ). Gastrointestinal losses of potassium usually are due to prolonged diarrhea or vomiting, chronic laxative abuse, intestinal obstruction or infections. An
European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany
Search for other papers by Daniel Alexander Hescheler in
Google Scholar
PubMed
Search for other papers by Milan Janis Michael Hartmann in
Google Scholar
PubMed
Search for other papers by Burkhard Riemann in
Google Scholar
PubMed
Search for other papers by Maximilian Michel in
Google Scholar
PubMed
Search for other papers by Christiane Josephine Bruns in
Google Scholar
PubMed
Search for other papers by Hakan Alakus in
Google Scholar
PubMed
Search for other papers by Costanza Chiapponi in
Google Scholar
PubMed
Trametinib: MEK1, MEK2 ATC: 16 locally advanced or metastatic BRAF V600E mutant disease ORR Phase II, single arm, open label PR: 63% CR: 6% Skin papilloma hyperkeratosis, alopecia, fatigue, fever, diarrhea, acneiform rash Trametinib and
Department of Clinical Science, Department of Medicine, Department of Medicine, Pediatric Department, University of Bergen, Bergen, Norway
Search for other papers by Marianne C Astor in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Department of Medicine, Pediatric Department, University of Bergen, Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
Search for other papers by Anette S B Wolff in
Google Scholar
PubMed
Search for other papers by Bjørn Nedrebø in
Google Scholar
PubMed
Search for other papers by Eirik Bratland in
Google Scholar
PubMed
Search for other papers by Jon Steen-Johnsen in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Department of Medicine, Pediatric Department, University of Bergen, Bergen, Norway
Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
supplementation Daily oral Mg supplementation (mmol/kg per day) d 0.8–1.0 0.5 0.4 0.5 1.6 Side effects of oral Mg Diarrhea Diarrhea Diarrhea None None Serum-Mg (mmol/l) 0.5–0.6 0.6 0.6–0.7 0.7–0.8 0.7 Urine-Mg (mmol/mmol creatinine) ref. range 0.20–0.50 0.03 0
Search for other papers by Alberto Bongiovanni in
Google Scholar
PubMed
Search for other papers by Federica Recine in
Google Scholar
PubMed
Search for other papers by Flavia Foca in
Google Scholar
PubMed
Search for other papers by Valentina Fausti in
Google Scholar
PubMed
Search for other papers by Nada Riva in
Google Scholar
PubMed
Search for other papers by Greta Fabbri in
Google Scholar
PubMed
Search for other papers by Stefano Severi in
Google Scholar
PubMed
Search for other papers by Chiara Liverani in
Google Scholar
PubMed
Search for other papers by Alessandro De Vita in
Google Scholar
PubMed
Search for other papers by Chiara Spadazzi in
Google Scholar
PubMed
Search for other papers by Giacomo Miserocchi in
Google Scholar
PubMed
Search for other papers by Laura Mercatali in
Google Scholar
PubMed
Search for other papers by Dino Amadori in
Google Scholar
PubMed
Search for other papers by Toni Ibrahim in
Google Scholar
PubMed
every 4 weeks was administered in 26 patients. Treatment was very well tolerated, with only one case each of G1, G2 and G3 diarrhea recorded. G1 cholelithiasis was registered in three cases. Median OS was 5.7 years (95% CI: 4.2–7.0) in G1–G2 NEN patients
AESKU.KIPP Institute, Wendelsheim, Germany
Search for other papers by Aaron Lerner in
Google Scholar
PubMed
Search for other papers by Patricia Jeremias in
Google Scholar
PubMed
Search for other papers by Torsten Matthias in
Google Scholar
PubMed
’s thyroiditis Graves’ disease Weight Loss Gain Loss Bowel movement Diarrhea/constipation Constipation Diarrhea Joint/bone pain +/+ +/−, hypotonia Muscle weakness Fatigue/tiredness + + + Psychology
Search for other papers by Jordyn Silverstein in
Google Scholar
PubMed
Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, California, USA
Search for other papers by Wesley Kidder in
Google Scholar
PubMed
Search for other papers by Susan Fisher in
Google Scholar
PubMed
Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA
Search for other papers by Thomas A Hope in
Google Scholar
PubMed
Search for other papers by Samantha Maisel in
Google Scholar
PubMed
Department of Pathology, University of California, San Francisco, California, USA
Search for other papers by Dianna Ng in
Google Scholar
PubMed
Search for other papers by Jessica Van Ziffle in
Google Scholar
PubMed
Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, California, USA
Search for other papers by Chloe E Atreya in
Google Scholar
PubMed
Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, California, USA
Search for other papers by Katherine Van Loon in
Google Scholar
PubMed
-limited episode of diarrhea at 25 weeks gestational age for which she was diagnosed with acute gastroenteritis. At 37 weeks, a cesarean section was performed due to arrest of descent during labor. At 2 weeks post-partum, she began experiencing copious diarrhea
Search for other papers by Hanbaro Kim in
Google Scholar
PubMed
Search for other papers by Ki Byung Song in
Google Scholar
PubMed
Search for other papers by Dae Wook Hwang in
Google Scholar
PubMed
Search for other papers by Jae Hoon Lee in
Google Scholar
PubMed
Search for other papers by Shadi Alshammary in
Google Scholar
PubMed
Search for other papers by Song Cheol Kim in
Google Scholar
PubMed
variable clinical behavior. Functional PNETs (F-PNETs) are diagnosed on the basis of the presence of clinical symptoms such as hypoglycemia, diarrhea or peptic ulcer. Non-functional PNETs (NF-PNETs) are often discovered later, that is, at an advanced stage